Compositions comprising IL6R antibodies for the treatment of uveitis and macular edema and methods of using same
US10968278B2 · kind B2 · utility
1Cited by
6References
24Claims
0Family size
Assignees
Inventors
Key dates
| Filing date | Nov 3, 2016 |
| Grant date | Apr 6, 2021 |
| Priority date | — |
| Expiry date | Oct 15, 2037 |
Classification
- Technology area (CPC C)Chemistry; Metallurgy
- CPC primaryC07K2317/76
- WIPO fieldPharmaceuticals
- WIPO sectorChemistry
Abstract
The present invention provides compositions and methods of treating and improving the symptoms of uveitis and/or macular edema using an antibody that specifically binds human interleukin-6 receptor (hIL-6R).
Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.